IOL Chemicals and Pharmaceuticals Limited

rs,

Complex, Bandra (E) Mumbai - 400 051 Security Symbol: IOLCP BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street Mumbai – 400 001 Security Code: 524164 Subject: Investor Presentation-Q2 & H1 FY26.

₹ 567.5

international operations its core 3 Q2 & H1 FY26 Standalone Performance Highlights Q2 FY26 ₹ 567.5 Cr Revenue from Operations 7.9% YoY H1 FY26 ₹ 1,119.2 Cr Revenue from Operations 8.9% YoY ₹ 64.

7.9%

e 3 Q2 & H1 FY26 Standalone Performance Highlights Q2 FY26 ₹ 567.5 Cr Revenue from Operations 7.9% YoY H1 FY26 ₹ 1,119.2 Cr Revenue from Operations 8.9% YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA M

₹ 1,119.2

Standalone Performance Highlights Q2 FY26 ₹ 567.5 Cr Revenue from Operations 7.9% YoY H1 FY26 ₹ 1,119.2 Cr Revenue from Operations 8.9% YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr E

8.9%

FY26 ₹ 567.5 Cr Revenue from Operations 7.9% YoY H1 FY26 ₹ 1,119.2 Cr Revenue from Operations 8.9% YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr EBITDA 25.7% YoY EBITDA Margin

₹ 64.0

67.5 Cr Revenue from Operations 7.9% YoY H1 FY26 ₹ 1,119.2 Cr Revenue from Operations 8.9% YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr EBITDA 25.7% YoY EBITDA Margin 11.8% ₹ 30.0

33.3%

om Operations 7.9% YoY H1 FY26 ₹ 1,119.2 Cr Revenue from Operations 8.9% YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr EBITDA 25.7% YoY EBITDA Margin 11.8% ₹ 30.0 Cr Profit After

11.1%

H1 FY26 ₹ 1,119.2 Cr Revenue from Operations 8.9% YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr EBITDA 25.7% YoY EBITDA Margin 11.8% ₹ 30.0 Cr Profit After Tax 56.7% YoY PAT Marg

₹ 133.5

₹ 1,119.2 Cr Revenue from Operations 8.9% YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr EBITDA 25.7% YoY EBITDA Margin 11.8% ₹ 30.0 Cr Profit After Tax 56.7% YoY PAT Margin 5.2% ₹

25.7%

nue from Operations 8.9% YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr EBITDA 25.7% YoY EBITDA Margin 11.8% ₹ 30.0 Cr Profit After Tax 56.7% YoY PAT Margin 5.2% ₹ 64.0 Cr Profit

11.8%

YoY ₹ 64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr EBITDA 25.7% YoY EBITDA Margin 11.8% ₹ 30.0 Cr Profit After Tax 56.7% YoY PAT Margin 5.2% ₹ 64.0 Cr Profit After Tax 31.0% YoY PAT

₹ 30.0

64.0 Cr EBITDA 33.3% YoY EBITDA Margin 11.1% ₹ 133.5 Cr EBITDA 25.7% YoY EBITDA Margin 11.8% ₹ 30.0 Cr Profit After Tax 56.7% YoY PAT Margin 5.2% ₹ 64.0 Cr Profit After Tax 31.0% YoY PAT Margin 5

“Asia-Pacific—led by India and China posts the fastest growth at 8.7% CAGR.”

“Aiming to grow export revenue share to ~40% The company has acquired 101 acres of land alongside the Chandigarh- Bathinda Highway, near its existing facility, to support future expansion.”

Existing Facility

1

COMPANY

1

INVESTOR RELATIONS ADVISORS

1

Existing Facility

Spanning 180+ acres Expansion: Acquired 101 acres on Chandigarh- Bathinda Highway for new site development Zero Discharge Effluent Treatment Plant Largest producer of Ibuprofen and the only company worldwide being fully backward integrated Customer base across 80 countries DSIR-approved R&D facility with 50+ scientists driving innovation across APIs and specialty chemicals Over 20 products are commercialized with 9 products in pipeline Major producer of Ethyl Acetate in India with a capacity of 1,00,000 MTPA, and Acetic Anhydride with a capacity of 25,000 MTPA Debt to Equity Ratio 0.07 11 Segment Overview- Pharmaceuticals Largest global producer of Ibuprofen, with an annual capacity of 12,000 MT World’s only company with complete backward integration 15 DMFs with USFDA CEP certification received for 18 APIs; 2 additional CEP applications currently under review with EDQM Commenced a fully backward-integrated Unit-11 for Paracetamol manufacturing at Barnala, with an installed capacity of

COMPANY

IOL Chemicals and Pharmaceuticals Ltd. CIN : L24116PB1986PLC007030 Mr. Abhay Raj Singh - Sr. VP & Company Secretary E-mail: investor@iolcp.com www.iolcp.com investor@iolcp.com www.iolcp.com

INVESTOR RELATIONS ADVISORS

MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services prachi.ambre@in.mpms.mufg.com prachi.ambre@in.mpms.mufg.com Ms. Prachi Ambre prachi.ambre@in.mpms.mufg.com irfan.raeen@in.mpms.mufg.com irfan.raeen@in.mpms.mufg.com Mr. Irfan Raeen irfan.raeen@in.mpms.mufg.com Meeting Request Link Link Website: https://in.mpms.mufg.com/ Thank You